British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada.
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(Suppl 1):S23-6. doi: 10.1097/QAI.0b013e3181f9c203.
Comprehensive HIV prevention interventions are increasingly recognized as critical in the global effort to reduce HIV transmission among people who use injection drugs. Scientific evidence clearly shows that a variety of biomedical, behavioral, and structural interventions can prevent and reduce injection drug user-driven HIV epidemics, yet social and structural barriers to their implementation remain. This review discusses the scientific evidence on the effectiveness of individual programs for reducing HIV incidence among people who use injection drugs and how, by integrating individual programs as complements within a comprehensive HIV prevention approach, it is possible to achieve, and to sustain, greater results than those of individual programs alone. The article concludes with a discussion of a critical research priority; namely, to improve the implementation of comprehensive HIV prevention interventions in settings of prevalent injection drug use and to overcome the often complex barriers that impede them. Such an effort will require more than research alone, however. It will also require the ongoing commitment of policymakers, public health officials, and the affected communities themselves to use comprehensive HIV treatment and prevention as the most effective strategy to reduce new HIV infections.
综合艾滋病预防干预措施在全球范围内减少注射毒品使用者中艾滋病毒传播的努力中日益得到认可。科学证据清楚地表明,各种生物医学、行为和结构干预措施可以预防和减少注射毒品使用者驱动的艾滋病毒流行,但在实施这些干预措施方面仍存在社会和结构障碍。本文讨论了关于减少注射毒品使用者中艾滋病毒发病率的个别项目的有效性的科学证据,以及如何通过将个别项目整合为综合艾滋病毒预防方法的补充,实现并维持比个别项目单独取得更大的成果。文章最后讨论了一个关键的研究重点,即改善在注射毒品流行环境中实施综合艾滋病毒预防干预措施,并克服常常阻碍这些措施的复杂障碍。然而,这一努力不仅需要研究。它还需要政策制定者、公共卫生官员和受影响社区自身不断承诺将综合艾滋病毒治疗和预防作为减少新的艾滋病毒感染的最有效战略。